JPRN-UMIN000012301已完成未知
Pharmacokinetics differences in risperidone and 9-OH risperidone: relation to inserted depth of injection needle in the people with schizophrenia who treated with regularly risperidone long acting injection (RLAI). - Pharmacokinetics differences in risperidone and 9-OH risperidone: relation to inserted depth of injection needle in the people with schizophrenia who treated with regularly risperidone long acting injection (RLAI).
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients meeting any of the following criteria will be excluded from the study. 1) PANSS total score over 130 points. 2) Patients who need to be treated with risperidone or paliperidone during this research.
研究者
相似试验
招募中
3 期
Comparison of the effectiveness of risperidone and aripiprazole in controlling aggression in inpatient adolescents with conduct disorderConduct disorder.Conduct disordersIRCT20210718051932N1niversity of social welfare and rehabilitation sciences62
已完成
3 期
Impact of Risperidone in the treatment of fecal incontinence among childreFunctional constipation, Fecal incontinence, NDD.IRCT20200203046352N1Shahid Beheshti University of Medical Sciences140
尚未招募
3 期
Antipsychotic drug for autismCTRI/2021/12/038721AIIMS Rishikesh
尚未招募
Unknown
Comparison of Risperidone or Aripiprazole addition to Selective Serotonin Reuptake Inhibitors for treating Obsessive Compulsive DisorderCTRI/2024/06/069483Government Medical College and Hospital
尚未招募
4 期
A study of the safety of Risperidone with Olanzapine in new psychosis patientsCTRI/2024/07/071680DrRajendra Prasad Government Medical college